- Left Ventricular Assist Device under Chronic Kidney Disease: Cautious, But We Still Need More Details
-
Lee SY
- KMID: 2532600
- Int J Heart Fail.
- 2021 Jan;3(1):78-80.
- doi: 10.36628/ijhf.2020.0051
-
- CITED
-
- Close
- SHARE
-
- Close
- Remote Patient Monitoring in Heart Failure: Factors for Clinical Efficacy
-
Bhatia A, Maddox TM
- KMID: 2532594
- Int J Heart Fail.
- 2021 Jan;3(1):31-50.
- doi: 10.36628/ijhf.2020.0023
Despite clinical advances in its treatment, heart failure (HF) is associated with significant adverse clinical outcomes and is among the greatest drivers of healthcare utilization. Outpatient management of HF remains suboptimal,... -
- CITED
-
- Close
- SHARE
-
- Close
- Rationale and Study Design of the Withdrawal of Spironolactone for Heart Failure with Improved Left Ventricular Ejection Fraction
-
Hyun J, Lee SE, Lee SA, Hong JA, Kim MS, Kim JJ
- KMID: 2532596
- Int J Heart Fail.
- 2021 Jan;3(1):51-58.
- doi: 10.36628/ijhf.2020.0044
It is unclear if guideline-directed medical therapy (GDMT) should be maintained in patients who have heart failure (HF) with improved ejection fraction (HFiEF). Of the medications recommended for HF, mineralocorticoid... -
- CITED
-
- Close
- SHARE
-
- Close
- Heart Transplant Immunosuppression Strategies at Cedars-Sinai Medical Center
-
Chang DH, Youn JC, Dilibero D, Patel JK, Kobashigawa JA
- KMID: 2532589
- Int J Heart Fail.
- 2021 Jan;3(1):15-30.
- doi: 10.36628/ijhf.2020.0034
Heart transplant is the optimal treatment for selected patients with end-stage heart failure. Immunosuppression after heart transplantation has significantly reduced the incidence of rejection and improved patient outcomes with the routine... -
- CITED
-
- Close
- SHARE
-
- Close
- Cardiac Rehabilitation in Heart Failure
-
Chun Kh, Kang SM
- KMID: 2532591
- Int J Heart Fail.
- 2021 Jan;3(1):1-14.
- doi: 10.36628/ijhf.2020.0021
Heart failure (HF) is a complex clinical syndrome caused by a structural and/or functional cardiac abnormality, resulting in reduced organ perfusion. The goals of treatment in patients with HF are... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of Renal Dysfunction on Outcomes after Left Ventricular Assist Device: A Systematic Review
-
Ibrahim M, Saint Croix GR, Lacy S, Chaparro S
- KMID: 2532599
- Int J Heart Fail.
- 2021 Jan;3(1):69-77.
- doi: 10.36628/ijhf.2020.0030
Background and Objectives: Renal dysfunction is a common comorbidity in patients with advanced heart failure who may benefit from left ventricular assist device (LVAD) therapy. The effect of preoperative renal dysfunction... -
- CITED
-
- Close
- SHARE
-
- Close
- Endurance Exercise Training Prevents Elevation of Soluble ST2 in Mice with Doxorubicin-Induced Myocardial Injury
-
Kim BJ, Choi JY, Oh SJ, Heo JH
- KMID: 2532598
- Int J Heart Fail.
- 2021 Jan;3(1):59-68.
- doi: 10.36628/ijhf.2020.0026
Background and Objectives: Endurance exercise training (ET) can improve outcomes for patients with heart failure (HF). We investigated the preventive effects of ET on serum biomarkers for HF in mice... -
- CITED
-
- Close
- SHARE
-
- Close
